Latest News and Press Releases

Beam Global reports Q1 2026 results with $9M backlog, accelerating international growth, and Q2 revenue already surpassing total Q1 revenue.

SUNNYVALE, Calif., May 15, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...

Beam Global to report Q1 2026 results May 15 after market close and host a conference call at 4:30 p.m. ET with corporate updates.

- Halneuron® Phase 2b trial in Chemotherapy Induced Neuropathy on track for top-line results in fall 2026 - - FDA acceptance of SP16 Investigational New Drug Application for the treatment of...

CICERO, Illinois, May 12, 2026 (GLOBE NEWSWIRE) -- Broadwind (Nasdaq: BWEN, or the “Company”), a diversified precision manufacturer of specialized components and solutions serving global markets,...

Liquidia reports Q1 2026 results: $129.9M in YUTREPIA net product sales and third consecutive quarter of profitability.

Revenue scaled ahead of plan; Q1 revenue of $3.0 million, up 238% sequentially and 578% year over year, reflecting growth across all offerings. Entered into additional vertical through acquisition...

ATLANTA, May 07, 2026 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a company that focuses on developing new medicines to treat pain and neuropathy,...

Liquidia (Nasdaq: LQDA) will report Q1 2026 financial results and host a corporate update webcast on Monday, May 11, 2026, at 8:30 a.m. ET.

CICERO, Ill., May 01, 2026 (GLOBE NEWSWIRE) -- Broadwind (Nasdaq: BWEN, or the “Company”), a diversified precision manufacturer of specialized components and solutions serving global markets, today...